Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Helix Kapital in conjunction with an investment in the Sensebit group
Mandate

Vinge advises Helix Kapital in conjunction with an investment in the Sensebit group

February 21, 2020 M&A

Vinge has advised the investment company Helix Kapital in connection with its entry as a majority owner in the Sensebit group, which is the market leader in the Nordic region in relation to data collection and analysis of traffic information. The co‑owners and management remain within the company as significant minority owners.

Vinge’s team primarily consisted of Johan Winnerblad, Johan Larsson, Christian Brelin (project manager), Tove Lövgren Frisk and Jesper Lindvall.

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

 Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

 Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024